International medicines governance 1940s to 1970s: lessons for public health

References

• Antezana, F. S. (1981). Essential drugs – Whose responsibility? Journal of the Royal Society of Medicine, 74, 175–177.
   PubMed Web of Science ®Google Scholar
• Antezana, F., & Seuba, X. (2009). Thirty years of essential medicines: The challenge. Valencia Spain: Farmamudi.
   Google Scholar
• Asian-African Conference of Bandung. (1955). Final Communiqué. Retrieved August 10, 2013, from http://www.ena.lu/final_communique_asian_african_conference_bandung_24_april_1955-2-1192
   Google Scholar
• Baer, W. (1972). Import substitution and industrialization in Latin America: Experiences and interpretations. Latin American Research Review, 7, 95–122.
   Web of Science ®Google Scholar
• Ballance, R., Pogany, J., & Forstner, H. (1992). The world's pharmaceutical industries. England: Edward Elgar.
   Google Scholar
• Baran, P. (1957). Political economy of growth. New York, NY: Monthly Review Press.
   Google Scholar
• Beall, R., & Kuhn, R. (2012). Trends in compulsory licensing of pharmacuteicals since the Doha declaration: A database analysis. PLoS Medicine, 9(1), 1–19.
   Web of Science ®Google Scholar
• Capo, L. R. (1983). International Drug Procurement and Market Intelligence: Cuba. In S. J. Patel (Ed.), Pharmacueticals and health in the Third World (pp. 217–222). Oxford: Pergamon Press.
   Google Scholar
• Cardoso, F., & Falsetto, E. (1979). Dependency and development in Latin America. Berkeley, CA: University of California Press.
   Google Scholar
• Carpenter, D. (2010). Reputation and power: Organizational image and pharmaceutical regulation at the FDA. Princeton: Princeton University Press.
   Google Scholar
• Chisholm, B. (1950). The World Health Organization. British Medical Journal, 1, 1021–1027.10.1136/bmj.1.4661.1021
   PubMedGoogle Scholar
• Chorev, N. (2012). The World Health Organization between north and south. New York, NY: Cornell University Press.
   Google Scholar
• Chowdury, Z. (1995). The politics of essential drugs: The makings of a successful health strategy: Lessons from Bangladesh. London: Zed Press.
   Google Scholar
• Commission on Intellectual Property Rights, Innovation and Public Health. (2006). Public health, innovation and intellecutal property rights. Geneva: World Health Organization.
   Google Scholar
• Consultative Expert Working Group on Research and Development: Financing and Coordination (2012). Research and development to meet health needs in developing countries: Strengthening global financing and coordination. Geneva: World Health Organization.
   Google Scholar
• Cox, R. (1979). Ideologies and the New International Economic Order: Reflections on some recent literature. International Organization, 33, 257–302.10.1017/S0020818300032161
   Web of Science ®Google Scholar
• Deere, C. (2008). The implementation game. Oxford: Oxford University Press.10.1093/acprof:oso/9780199550616.001.0001
   Google Scholar
• Drahos, P. (1995). Global property rights in information: The story of TRIPS at the GATT. Prometheus, 13, 6–19.10.1080/08109029508629187
   Google Scholar
• Drahos, P., & Braithwaite, J. (2002). Information feudalism: Who owns the knowledge economy?. London: Earthscan.
   Google Scholar
• Farley, J. (2008). Brock Chisholm, the World Health Organization and the Cold War. Vancouver: UBC Press.
   Google Scholar
• Fifth Conference of Heads of State or Government of Non-Aligned Countries. (1976). Resolution of co-operation among developing countries in the production, procurement and distribution of pharmaceuticals, NAC/CONF.5/S/RES.25, Columbo, Sri Lanka.
   Google Scholar
• Frank, A. G. (1967). Capitalism and underdevelopment in Latin America: Historical studies of Chile and Brazil. New York, NY: Monthly Review Press.
   Google Scholar
• Frank, R. S. (1975, October 25). Economic report: U.S takes steps to meet demands of Third World nations. National Journal Reports, 1480–1489.
   Google Scholar
• Gleeson, D. H., Moir, H., & Lopert, R. (2015). Costs to Australian taxpayers of pharmaceutical monopolies and proposals to extend them in the Trans-Pacific Partnership Agreement. The Medical Journal of Australia, 202, 306–308.10.5694/mja14.01682
   PubMed Web of Science ®Google Scholar
• Gontijo, C. (2005). Changing the patent system: From the Paris convention to the TRIPS agreement – The position of Brazil. Global Issue Papers. Berlin: Heinrich-Böll Stiftung.
   Google Scholar
• Gosovic, B., & Ruggie, J. G. (1976). On the creation of a new international economic order: Issue linkage and the seventh special session of the UN general assembly. International Organization, 30, 309–345.
   Web of Science ®Google Scholar
• Greene, J. A. (2010). When did medicines become essential? Bulletin of the World Health Organization, 88, 483.10.2471/BLT.10.079970
   PubMed Web of Science ®Google Scholar
• Greer, D. (1973). The case against patent systems in less developed countries. The Journal of International Law and Economics, 8, 223–266.
   Google Scholar
• Grundmann, H. E. (1970). The economic arguments for patents and their validity for developing countries. Indian Economic Journal, 19, 193–207.
   Google Scholar
• Hardon, A. (1992). Consumers versus producers: Power play behind the scenes. In N. Kanji, A. Hardon, J. Harnmeijer, M. Mamdani, & G. Walt (Eds.), Drugs policy in developing countries (pp. 48–62). London: Zed Books.
   Google Scholar
• Hirono, H., Haigh, F., Gleeson, D., Thow, H. P., & Thow, A. M. (2015). Negotiating healthy trade in Australia: Health impact assessment of the proposed Trans Pacific Partnership Agreement. Liverpool: Centre for Health Equity Training Research and Evaluation, UNSW Australia.
   Google Scholar
• Ikenberry, G. (1986). The irony of state strength: Comparative responses to the oil shocks in the 1970s. International Organization, 40, 105–137.10.1017/S0020818300004495
   Web of Science ®Google Scholar
• Laing, R., Waning, B., Gray, A., Ford, N., & t’Hoen, E. (2003). 25 years of the WHO essential medicines lists: Progress and challenges. The Lancet, 361, 1723–1729.10.1016/S0140-6736(03)13375-2
   PubMed Web of Science ®Google Scholar
• Lall, S. (1974). The international pharmaceutical industry and less-developed countries, with special reference to India. Oxford Bulletin of Economics and Statistics, 36, 145–172.
   Google Scholar
• Lee, K. (2009). The World Health Organization. Oxon: Taylor and Francis.
   Google Scholar
• Licklider, R. (1988). The power of oil: The Arab oil weapon and the Netherlands, the United Kingdom, Canada, Japan, and the United States. International Studies Quarterly, 32, 205–226.
   Web of Science ®Google Scholar
• Love, J. (2002). Benefits of a treaty on R&D. Washington, DC: Consumer Project on Technology.
   Google Scholar
• Mahler, H. (1975a). Director general report to the 29th WHA no. 226. Geneva: World Health Organization.
   Google Scholar
• Mahler, H. (1975b). Health for all by the year 2000. WHO Chronicle, 29, 457–461.
   PubMedGoogle Scholar
• Mamdani, M. (1992). Early initatives in essential drugs policy. In N. Kanji, A. Hardon, J. Harnmeijer, M. Mamdani, & G. Walt (Eds.), Drugs policy in developing countries (pp. 1–23). London: Zed Books.
   Google Scholar
• Mamdani, M., & Walker, G. (1985). Essential drugs and developing countries. London: London School of Hygiene and Tropical Medicine.
   Google Scholar
• May, C. (2010). The political economy of intellectual property rights (2nd ed.). New York, NY: Routledge.10.4337/9781785362118
   Google Scholar
• McTurnan, G. (1956). The Asian-African conference: Bandung, Indonesia, April 1955. New York, NY: Cornell University Press.
   Google Scholar
• Microsoft. (2002). Response to patent office consultation on the report of the commission on intellectual property rights. Retrieved December 20, 2013, from http://www.iprcommission.org/graphic/Views_articles/Microsoft.htm
   Google Scholar
• United Nations General Assembly. (1974). Resolution adopted by the general assembly 3201 (S-VI) declaration on the establishment of a new international economic order. Geneva: United Nations.
   Google Scholar
• Okediji, R. L. (2003). The international relations of intellectual property: Narratives of developing country participation in the global intellectual property system. Singapore Journal International and Comparative Law, 7, 215–285.
   Google Scholar
• Paris Convention for the Protection of Industrial Property. (1883, March 20). Retrieved February 20, 2014, from http://www.wipo.int/treaties/en/ip/paris/trtdocs_wo020.html
   Google Scholar
• Penrose, E. (1973). International patenting and the less-developed countries. The Economic Journal, 83, 768–786.10.2307/2230670
   Web of Science ®Google Scholar
• Piachaud, D. (1980). Medicines and the Third World. Social Science and Medicine, 14, 183–189.
   Web of Science ®Google Scholar
• Prashad, V. (2007). The darker nations: A biography of the short-lived Third World. New Delhi: LeftWord.
   Google Scholar
• Program on Information Justice and Intellectual Property. (2009). Timeline for US-Thailand compulsory license dispute. American University Washington College of Law. Retrieved April 22, 2015, from http://infojustice.org/wp-content/uploads/2012/11/pijip-thailand-timeline.pdf
   Google Scholar
• Reich, M. (1987). Essential drugs: Economics and politics in international health. Health Policy, 8, 39–57.10.1016/0168-8510(87)90129-1
   Web of Science ®Google Scholar
• Reich, M. (1995). The politics of health sector reform in developing countries: Three cases of pharmaceutical policy. Health Policy, 32, 47–77.10.1016/0168-8510(95)00728-B
   PubMed Web of Science ®Google Scholar
• Ricketson, S. (1987). The Berne convention for the protection of literary and artistic works: 1886–1986. London: Kluwer Centre for Commercial Law Studies.
   Google Scholar
• Roffe, P. (1985). Transfer of technology: UNCTAD's draft international code of conduct. Current Developments, 19, 689–707.
   Google Scholar
• Sell, S. K. (1998). Power and ideas: North-south politics of intellectual property and antitrust. SUNY Series Global Politics. New York, NY: State University of New York Press.
   Google Scholar
• Sell, S. K. (2003). Private power, public law. Cambridge: Cambridge University Press.10.1017/CBO9780511491665
   Google Scholar
• Sneyd, A. (2005). New International Economic Order (NIEO). Winnipeg: Globalization and Autonomy Online Compendium.
   Google Scholar
• Stiglitz, J. E. (2006, September 17). Innovation: A better way than patents, New Scientist. Retrieved July 24, 2013, from www.newscientist.com/article/dn10090-innovation-a-better-way-than-patents.html
   Google Scholar
• Taggart, J. H. (1993). The world pharmaceutical industry. London: Routledge.
   Google Scholar
• Thomas, C. (1998). Transfer of technology in the contemporary international order. Fordham International Law Journal, 22, 2096–2111.
   Google Scholar
• Thompson, T. (2003). US proposed resolution on IPR, Innovation and Public Health, May 21st 2003. IP-health, Retrieved June 24, 2013, from http://lists.essential.org/pipermail/ip-health/2003-May/004764.html
   Google Scholar
• Tiefenbacher, M. (1977). World pharmaceutical news. SCRIP 259.
   Google Scholar
• Turshen, M. (2001). Reprivatizing pharmaceutical supplies in Africa. Journal of Public Health Policy, 22, 198–225.10.2307/3343460
   PubMed Web of Science ®Google Scholar
• UNCTAD. (1975). The international patent system as an instrument of policy for national development. TD/B/C.6/AC.2/3, Geneva: UNCTAD.
   Google Scholar
• UNCTAD. (1976). Technology Policy in the Pharmaceutical Sector in Developing Countries. WHO Consultation on Drug Policies. Geneva: UNCTAD.
   Google Scholar
• UNCTAD. (1977). The international patent system: The revision of the Paris convention for the protection of industrial property. TD/B/C.6/AC.3/2. Geneva: UNCTAD.
   Google Scholar
• UNCTAD. (1980). Strengthening the technological capacity of the developing countries including accelerating their technological transformation: Issues in individual aectors and other areas of critical importance to developing countries. TD/B/C.6/56. Geneva: UNCTAD.
   Google Scholar
• UNCTAD. (2001). Transfer of technology. Geneva: IIA Issues Paper Series.
   Google Scholar
• UNCTC. (1984). Transnational corporations in the pharmaceutical industry of developing countries. New York, NY: UNCTC.
   Google Scholar
• UNESA, UNCTAD, & WIPO. (1975). The role of the patent system in the transfer of technology to developing countries. TD/B/AC.11/19/rev.1. New York, NY: United Nations.
   Google Scholar
• UNESC. (1981). Transnational corporations in the pharmaceutical industry of developing countries: Report of the secretariat. E/C.10/85. New York, NY: United Nations.
   Google Scholar
• UNICEF-WHO Joint Committee on Health Policy Session. (1987). UNICEF/WHO joint programme on provision of essential drugs for primary health care in developing countries. JC26/UNICEF-WHO/87.7 Unpublished document, Geneva.
   Google Scholar
• UNIDO. (1978). The growth of the pharmaceutical industry in developing countries. New York, NY: United Nations.
   Google Scholar
• United Nations General Assembly. (1961). Resolution 1713 (XVI) on the role of patents in the transfer of technology to underdeveloped countries. New York, NY: United Nations.
   Google Scholar
• United Nations General Assembly. (1976). Documents of the fifth conference of heads of state of government of non-aligned countries. A/31/197. Geneva: United Nations.
   Google Scholar
• Vaitsos, C. V. (1972). Patents revisited: Their function in developing countries. The Journal of Development Studies, 9, 71–97.10.1080/00220387208421432
   Google Scholar
• Walt, G., & Harnmeijer, J. (1992). Formulating an essential drugs policy: WHO's role. In N. Kanji, A. Hardon, J. Harnmeijer, M. Mamdani, & G. Walt (Eds.), Drugs policy in developing countries (pp. 24–42). London: Zed Books.
   Google Scholar
• White, J., & Moss, A. G. (1978). Issues and prospects for the new international economic order. International Affairs (Royal Institute of International Affairs 1944-), 54, 626–640.10.2307/2617309
   Web of Science ®Google Scholar
• White, R. C. A. (1975). A new international economic order. International and Comparative Law Quarterly, 24, 542–552.10.1093/iclqaj/24.3.542
   Google Scholar
• WHO. (1964). Official records of the World Health Organization. Geneva: World Health Organization.
   Google Scholar
• WHO. (1973a). Handbook of resolutions and decisions of the world health assembly and executive board (Vol. 1, pp. 1948–1972). Geneva: World Health Organization.
   Google Scholar
• WHO. (1973b). Official records of the World Health Organization. Geneva: World Health Organization.
   Google Scholar
• WHO. (1974a). Intensification of research on tropical parasitic diseases resolution WHA27.52. Retrieved October 8, 2013, from http://www.who.int/tdr/about/governance/basic_documents/wha27_52/en/index.html
   Google Scholar
• WHO. (1974b). Official records of the World Health Organization. Geneva: World Health Organization.
   Google Scholar
• WHO. (1975). Official records of the World Health Organization. Geneva: World Health Organization.
   Google Scholar
• WHO. (1976), Intensification of research on parasitic and other communicable and tropical diseases resolution WHA29.71. Geneva: World Health Organization.
   Google Scholar
• WHO. (1977). The selection of essential drugs: Report of a WHO expert committee. Geneva: World Health Organization.
   Google Scholar
• WHO. (1978). Memorandum of understanding on the administrative and technical structures of the special programme for research and training in tropical diseases. Retrieved October 8, 2013, from http://www.who.int/tdr/about/governance/basic_documents/mou/en/index.html
   Google Scholar
• WHO. (1981). Global strategy for health for all by the year 2000. Retrieved August 17, 2012, http://whqlibdoc.who.int/publications/9241800038.pdf
   Google Scholar
• WHO. (1985a). Handbook of resolutions and decisions of the world health assembly and the executive board (Vol. 2, pp. 1972 – 1984). Geneva: World Health Organization.
   Google Scholar
• WHO. (1985b). The rational use of drugs: Report of the conference of experts Nairobi 25–29 November 1985. s17054e. Geneva: World Health Organization.
   Google Scholar
• WHO. (2008). Third ten years of the World Health Organization: 1968–1978. Albany, NY: World Health Organization.
   Google Scholar
• WHO. (2013). WHO reform: Financing of WHO. Provisional agenda item 11 to Sixty-sixth World Health Assembly, A66/48. Retrieved April 28, 2015, from http://apps.who.int/gb/ebwha/pdf_files/WHA66/A66_48-en.pdf
   Google Scholar
• WHO and UNICEF. (1978, 6–12 September). Declaration of Alma-Ata. In International conference on primary health care, Alma-Ata, USSR.
   Google Scholar
• WTO. (2001). Declaration on the TRIPS agreement and public health. WT/MIN(01)/DEC/2. Retrieved April 10, 2015, from https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm
   Google Scholar
• WTO. (2006). Fact sheet: TRIPS and pharmaceutical patents: Obligations and exceptions. Retrieved April 27, 2015, from https://www.wto.org/english/tratop_e/trips_e/factsheet_pharm02_e.htm
   Google Scholar